Skip to main content

Table 2 Overview of primary and secondary outcomes measures

From: The effect of virtual specialist conferences between endocrinologists and general practitioners about type 2 diabetes: study protocol for a pragmatic randomized superiority trial

Aspect

Outcome measure

Primary clinical outcome measures

Percentage of patients with T2D and ischemic heart disease and/or stroke being treated with glucagon-like peptide 1 receptor agonists (GLP1-RA) and sodium glucose cotransporter 2 (SGLT2) inhibitor

Percentage of patients with T2D and micro/macro-albuminuria being treated with angiotensin-converting-enzyme-inhibitor (ACE) or angiotensin-2-receptorantagonist (AT2)

Percentage of patients with T2D and LDL > 2.5 mmol/L being treated with statins

Secondary clinical outcome measures

Percentage of patients with T2D and HbA1c < 58 mmol/L

Percentage of patients with T2D and HbA1c < 53 mmol/L

Percentage of patients with T2D and blood pressure < 140 mmHg

Percentage of patients with T2D and blood pressure < 130 mmHg

Percentage of patients with T2D and low-density lipoprotein > 2.5 mmol/L

Percentage of patients with T2D and microalbuminuria and LDL > 1.8 mmol/L

Primary competence and organization outcome measures

The extent to which the GP is confident managing T2D in general

The extent to which the GP is skilled in making decisions on T2D in general

The extent to which the GP is confident managing T2D and ischemic heart disease, stroke, peripheral artery disease, and heart failure

The extent to which the GP is confident managing T2D and blood pressure

The extent to which the GP is confident managing T2D and kidney disease

The extent to which the GP is confident managing T2D and cholesterol

Secondary competence and organization outcome measures

GPs rating of the degree of relational coordination within the general practice

GPs rating of the degree of relational coordination with the endocrinology department

GPs rating of using virtual conferences based on the Technology Acceptance Model

The extent to which the practice staff is confident managing T2D in general

The extent to which the practice staff is confident managing T2D and ischemic heart disease, stroke, peripheral artery disease, and heart failure

The extent to which the practice staff is confident managing T2D and blood pressure

The extent to which the practice staff is confident managing T2D and kidney disease

The extent to which the practice staffs is confident managing T2D and cholesterol

Practice staffs’ rating of the degree of relational coordination within the general practice

Practice staffs’ rating of the degree of relational coordination with the endocrinology department

Practice staffs’ rating of using virtual conferences based on the Technology Acceptance Model